Cortical neurochemistry in euthymic patients with bipolar I disorder

References

• Bertolino A, Frye M, Callicott JH, et al. Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 2003; 53: 906–913
   PubMed Web of Science ®Google Scholar
• Bertolino A, Callicott JH, Elman I, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43: 641–648
   PubMed Web of Science ®Google Scholar
• Brambilla P, Stanley JA, Nicoletti MA, et al. 1H magnetic resonance spectroscopy investigation of the dorsolateral prefrontal cortex in bipolar disorder patients. J Affect Disord 2005; 86: 61–67
   PubMedGoogle Scholar
• Brambilla P, Stanley JA, Sassi RB, et al. 1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 2004; 29: 1918–1924
   PubMed Web of Science ®Google Scholar
• Block W, Bayer TA, Tepest R, et al. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett 2000; 289: 147–151
   Web of Science ®Google Scholar
• Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging 2001; 13: 560–567
   PubMed Web of Science ®Google Scholar
• Cecil KM, DelBello MP, Morey R, Strakowski SM. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 2002; 4: 357–365
   PubMed Web of Science ®Google Scholar
• Cecil KM, Lenkinski RE, Gur RE, Gur RC. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 1999; 20: 131–140
   PubMed Web of Science ®Google Scholar
• Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem 2000; 75: 1729–1734
   PubMed Web of Science ®Google Scholar
• Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 2004; 61: 450–458
   PubMed Web of Science ®Google Scholar
• Duvernoy HM. The human brain. Surface, three-dimensional sectional anatomy and MRI and blood supply. Springer, Wien 1999
   Google Scholar
• Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N. Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 1999; 29: 639–644
   PubMed Web of Science ®Google Scholar
• Jessen F, Scherk H, Traber F, et al. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr Res 2006; 87: 81–88
   PubMedGoogle Scholar
• Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 2000; 48: 740–754
   PubMed Web of Science ®Google Scholar
• McDonald C, Zanelli J, Rabe-Hesketh S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004; 56: 411–417
   PubMed Web of Science ®Google Scholar
• Moore CM, Breeze JL, Gruber SA, et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000; 2: 207–216
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Parrish JK, et al. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 1999; 156: 1902–1908
   PubMed Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000a; 356: 1441–1442
   Google Scholar
• Moore GJ, Bebchuk JM, Hasanat K, et al. Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?. Biol Psychiatry 2000b; 48: 1–8
   PubMed Web of Science ®Google Scholar
• Ohrmann P, Siegmund A, Suslow T, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naïve and chronic medicated schizophrenic patients: A proton magnetic resonance spectroscopy study. J Psychiatr Res 2007; 41: 625–634
   Google Scholar
• Phillips ML, Drevets WC, Rauch SL, Lane R. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol Psychiatry 2003; 54: 515–528
   PubMed Web of Science ®Google Scholar
• Sassi RB, Nicoletti M, Brambilla P, et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett 2002; 329: 243–245
   PubMed Web of Science ®Google Scholar
• Scherk H, Reith W, Falkai P. Changes in brain structure in bipolar affective disorders. Der Nervenarzt 2004; 75: 861–872
   Google Scholar
• Silverstone PH, McGrath BM, Kim H. Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 2005; 7: 1–10
   PubMed Web of Science ®Google Scholar
• Soares JC, Mann JJ. The anatomy of mood disorders – review of structural neuroimaging studies. Biol Psychiatry 1997; 41: 86–106
   PubMed Web of Science ®Google Scholar
• Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005; 30: 1949–1962
   PubMed Web of Science ®Google Scholar
• Talairach P. Tournoux. Coplanar stereotaxic atlas of the human brain. Thieme Medical Publishers, New York 1998
   Google Scholar
• Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA. Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47: 475–481
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Zaudig M, Fydrich T. Strukturiertes klinisches Interview für DSM-IV Achse I und II. Hogrefe, Göttingen 1997
   Google Scholar
• Wobrock, T, Scherk, H, Falkai, P. 2005. Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations. Radiologe, 45:124–30, 132–136.
   Google Scholar